American Kidney Fund

Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease

Retrieved on: 
Thursday, February 29, 2024

During Kidney Month, AKF calls on members of the kidney community and the general public to join in solidarity in support of everyone affected by kidney disease.

Key Points: 
  • During Kidney Month, AKF calls on members of the kidney community and the general public to join in solidarity in support of everyone affected by kidney disease.
  • One of the hallmarks of Kidney Month at AKF is Kidney Action Week , which will be held March 18-22.
  • This free, virtual event will bring together patients, nephrologists, renal dieticians, caregivers and other kidney experts for a weeklong series of sessions about a variety of topics related to kidney disease, including dialysis, kidney disease prevention, kidney-friendly eating, transplant, innovations in kidney disease and more.
  • In addition, people with kidney disease have a higher chance of developing other health problems, such as heart disease.

Where You Live Impacts Your Ability to Save a Life Through Living Organ Donation, According to the 2024 American Kidney Fund Report Card

Retrieved on: 
Thursday, February 22, 2024

Receiving a kidney from a living donor is the best option for someone in need of a new kidney.

Key Points: 
  • Receiving a kidney from a living donor is the best option for someone in need of a new kidney.
  • However, six states – Alabama, Montana, New Hampshire, Tennessee, South Dakota and Vermont – have zero policy protections (F grade) for living organ donors.
  • How All 50 States + DC Fared on the 2024 State of the States: American Kidney Fund Report Card
    Currently, chronic kidney disease (CKD) affects more than 1 in 7 adults in the U.S.
  • “Where you live should not impact whether you are able to save a life through kidney donation, but our 2024 Report Card suggests that this may be the case.

Panoramic Health Launches Scientific Advisory Board to Accelerate Innovation in Kidney Care

Retrieved on: 
Thursday, March 7, 2024

TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Today, Panoramic Health, kidney care's leading integrated provider group, is proud to announce the establishment of its Scientific Advisory Board, a distinguished group of clinical leaders and research experts committed to advancing kidney care innovation. With a focus on uncovering and delivering cutting-edge treatments for patients with kidney disease, the advisory board will play a crucial role in guiding Panoramic Science, the company's clinical research division.

Key Points: 
  • TEMPE, Ariz., March 7, 2024 /PRNewswire/ -- Today, Panoramic Health, kidney care's leading integrated provider group, is proud to announce the establishment of its Scientific Advisory Board, a distinguished group of clinical leaders and research experts committed to advancing kidney care innovation.
  • "At Panoramic Health, we are dedicated to redefining the standard of kidney care through innovation and collaboration," said Dr. Rajiv Poduval, Co-Founder and Executive Chairman of Panoramic Health.
  • "Our Scientific Advisory Board brings together exceptional expertise that will drive our efforts to enhance patient care and transform the evolving landscape of kidney disease treatment.
  • Panoramic Health leadership team members serving on the advisory board include:
    The establishment of the Scientific Advisory Board underscores Panoramic Health's commitment to driving innovation and improving the lives of patients with kidney disease.

American Kidney Fund Announces April 30 as the First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day

Retrieved on: 
Thursday, January 25, 2024

ROCKVILLE, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce that April 30, 2024 will mark the nation’s first ever AMKD Awareness Day .

Key Points: 
  • ROCKVILLE, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce that April 30, 2024 will mark the nation’s first ever AMKD Awareness Day .
  • Building on AKF’s educational campaign for the condition, AMKD Awareness Day aims to spread awareness of APOL1-mediated kidney disease (AMKD) , a spectrum of kidney diseases associated with variants (mutations) in the apolipoprotein L1 (APOL1) gene and linked to an increased risk for rapidly progressing kidney disease in people of Western and Central African descent.
  • People with two mutations are at higher risk of developing genetic forms of kidney disease such as focal segmental glomerulosclerosis (FSGS).
  • Additionally, AKF will provide resources and ways to engage and raise awareness of the important connection between APOL1 gene variants and kidney disease in the months ahead.

American Kidney Fund Hosts Fourth National Summit on Unknown Causes of Kidney Disease

Retrieved on: 
Tuesday, December 5, 2023

ROCKVILLE, Md., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will convene more than 100 medical leaders, patient advocates and academic and industry leaders for the fourth national summit of its Unknown Causes of Kidney Disease (UCKD) Project, which seeks to improve understanding of how undiagnosed or misdiagnosed causes of kidney disease directly impact patient care and outcomes.

Key Points: 
  • ROCKVILLE, Md., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will convene more than 100 medical leaders, patient advocates and academic and industry leaders for the fourth national summit of its Unknown Causes of Kidney Disease (UCKD) Project, which seeks to improve understanding of how undiagnosed or misdiagnosed causes of kidney disease directly impact patient care and outcomes.
  • This will be the first in-person summit after three years of virtual summits due to the pandemic.
  • This week’s summit, which will be held in Arlington, Virginia, will further explore how the kidney community can drive innovation in research, diagnosis and treatment of the underlying causes of kidney disease.
  • “Finding out the root cause of one’s kidney disease can bring crucial clinical insights to providers and have life-saving implications for individuals.

American Kidney Fund Renews Calls for Early Diagnosis and Treatment of Chronic Kidney Disease in New Report

Retrieved on: 
Thursday, November 30, 2023

Advocates urge the U.S. Preventive Services Task Force to make recommendations on screening for chronic kidney disease, and strongly support legislative action for direct Medicare reimbursement to genetic counselors.

Key Points: 
  • Advocates urge the U.S. Preventive Services Task Force to make recommendations on screening for chronic kidney disease, and strongly support legislative action for direct Medicare reimbursement to genetic counselors.
  • Educating health care providers and patients about kidney disease and treatment options: Patient advocates have identified patient education and navigation as major challenges.
  • Many people at high risk aren’t aware of their risk factors and don’t know when to ask for screening for kidney disease.
  • The report also recommends identifying opportunities for advocates and policymakers to weigh in on policies that impact chronic kidney disease care.

Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2023 Corporate Membership Program at ‘Champion’ Level

Retrieved on: 
Friday, October 6, 2023

ROCKVILLE, Md., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2023 class in AKF’s Corporate Membership Program as a Champion-level member.

Key Points: 
  • ROCKVILLE, Md., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2023 class in AKF’s Corporate Membership Program as a Champion-level member.
  • Boehringer Ingelheim and Lilly’s membership helps fund AKF’s work to advance kidney disease awareness, prevention, early detection, treatment and research.
  • “AKF is pleased to continue our partnership with Boehringer Ingelheim and Lilly in the fight against kidney disease,” said LaVarne A. Burton, AKF President and CEO.
  • “Boehringer Ingelheim and Lilly are proud to continue to champion the work of the AKF by joining the Corporate Membership Program for the second consecutive year,” said Brian DiDonato, Senior Vice President, Cardio-Renal-Metabolic Brands at Boehringer Ingelheim.

CARS Launches Second Annual "Cartober" Campaign in Partnership with DAV and KPBS

Retrieved on: 
Monday, October 2, 2023

SAN DIEGO, Oct. 2, 2023 /PRNewswire-PRWeb/ -- San Diego-based nonprofit CARS (Charitable Adult Rides and Services) is launching its second annual Cartober campaign, a month-long awareness initiative designed to promote the power of vehicle donations in supporting nonprofits. With featured partners such as Disabled American Veterans (DAV), KPBS, American Kidney Fund, SPCA Monterey County, and Goodwill SoCal on board, Cartober 2023 aims to drive even more impact and support for worthy causes.

Key Points: 
  • San Diego-based nonprofit CARS (Charitable Adult Rides and Services) is launching its second annual Cartober campaign, an initiative that promotes vehicle donations for nonprofits throughout the month of October.
  • SAN DIEGO, Oct. 2, 2023 /PRNewswire-PRWeb/ -- San Diego-based nonprofit CARS (Charitable Adult Rides and Services) is launching its second annual Cartober campaign, a month-long awareness initiative designed to promote the power of vehicle donations in supporting nonprofits.
  • The campaign encourages people to donate their cars, trucks, RVs, boats, and other vehicles to benefit their chosen nonprofits.
  • "We are thrilled to launch the second year of Cartober in partnership with some amazing nonprofits like DAV and KPBS," said Justin Ruffier, VP of Marketing at CARS.

American Kidney Fund Launches Educational Awareness Campaigns for Two Rare Kidney Diseases

Retrieved on: 
Tuesday, September 26, 2023

ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) launched educational awareness campaigns for two rare kidney diseases: complement 3 glomerulopathy (C3G) and IgA nephropathy (IgAN).

Key Points: 
  • ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) launched educational awareness campaigns for two rare kidney diseases: complement 3 glomerulopathy (C3G) and IgA nephropathy (IgAN).
  • The campaigns, sponsored by Novartis, provide patients with information about the diseases and connect them with resources to help them better understand and manage these conditions.
  • C3G and IgAN are two types of kidney diseases that are related to improper function of the immune system, which is your body's cells and tissues that fight infection.
  • The C3G and IgAN campaigns are part of AKF’s ongoing work to increase awareness and understanding of rare kidney diseases and ensure people with these conditions have access to critical resources.

Florida Dialysis Centers Market Size, Share & Trends Analysis Report 2023: A $1.3 Billion Market by 2030 - Escalating Demand for Dialysis Units Propelling Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, September 15, 2023

The "Florida Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-Center, In-Home, SNF-based), By Dialysis Type (Hemodialysis, Peritoneal Dialysis), By Facility Type, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Florida Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-Center, In-Home, SNF-based), By Dialysis Type (Hemodialysis, Peritoneal Dialysis), By Facility Type, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • According to the American Kidney Fund, Florida is home to approximately 48,215 individuals grappling with End-Stage Renal Disease (ESRD).
  • The escalating demand for dialysis units across the state of Florida emerges as a pivotal factor expected to propel market growth in the coming years.
  • As of April 2023, DaVita owns or manages more than 200 outpatient dialysis centers in Florida